T M Hyers, R D Hull, J G Weg. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Administration, OralClinical Trials as TopicCost-Benefit AnalysisDrug MonitoringFibrinolytic Agents/administration & dosageFibrinolytic Agents/economicsFibrinolytic Agents/therapeutic useHumansRisk FactorsThromboembolism/drug therapyThromboembolism/economicsThrombolytic Therapy/economicsTime Factors
Substances: See more » Fibrinolytic Agents
Year: 1995 PMID: 7555187 DOI: 10.1378/chest.108.4_supplement.335s
Source DB: PubMed Journal: Chest ISSN: 0012-3692 Impact factor: 9.410